ASP Isotopes (NASDAQ:ASPI) Given Buy Rating at Canaccord Genuity Group

Canaccord Genuity Group reaffirmed their buy rating on shares of ASP Isotopes (NASDAQ:ASPI) in a research report sent to investors on Friday, Benzinga reports. The brokerage currently has a $4.50 price objective on the stock.

ASPI has been the topic of several other research reports. HC Wainwright decreased their target price on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating on the stock in a report on Wednesday, August 7th. Canaccord Genuity Group began coverage on shares of ASP Isotopes in a research report on Friday, October 4th. They set a “buy” rating and a $4.50 price target on the stock.

ASP Isotopes Price Performance

NASDAQ:ASPI opened at $4.84 on Friday. The company has a quick ratio of 4.00, a current ratio of 4.00 and a debt-to-equity ratio of 2.06. The firm has a market cap of $250.53 million, a PE ratio of -9.13 and a beta of 5.11. ASP Isotopes has a 12 month low of $0.99 and a 12 month high of $5.67. The company’s 50-day moving average price is $2.72 and its two-hundred day moving average price is $3.25.

ASP Isotopes (NASDAQ:ASPI) last announced its earnings results on Monday, August 19th. The company reported ($0.24) EPS for the quarter. The firm had revenue of $1.02 million during the quarter. On average, equities analysts anticipate that ASP Isotopes will post -0.24 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in shares of ASP Isotopes by 479.1% during the first quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock valued at $4,217,000 after acquiring an additional 844,705 shares during the period. Marshall Wace LLP lifted its position in ASP Isotopes by 389.6% during the 2nd quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock valued at $1,668,000 after purchasing an additional 433,734 shares during the period. Bank of New York Mellon Corp acquired a new position in ASP Isotopes during the 2nd quarter valued at about $381,000. HTLF Bank boosted its stake in shares of ASP Isotopes by 197.0% in the 2nd quarter. HTLF Bank now owns 105,538 shares of the company’s stock valued at $323,000 after purchasing an additional 70,000 shares during the last quarter. Finally, Virtu Financial LLC grew its position in shares of ASP Isotopes by 477.0% during the 1st quarter. Virtu Financial LLC now owns 83,677 shares of the company’s stock worth $346,000 after buying an additional 69,176 shares during the period. 16.80% of the stock is currently owned by institutional investors.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.